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Background
Natriuretic peptide receptor-A (NPR-A) is a transmem-
brane receptor guanylyl cyclase that binds and mediates
the effects of atrial and B-type natriuretic peptides (ANP/
BNP). Internalization and ligand-dependent degradation
of NPR-A is controversial, in part due to the use of ligand
binding studies to predict the cellular location of the
receptor. Here, we used a more direct sequential immuno-
precipitation-western blot assay to demonstrate that long-
term ANP exposure increases NPR-A degradation in pri-
mary, immortalized, and transfected cells.
Results
A separate novel extracellular epitope antibody-binding
assay indicated that NPR-A is internalized under basal
conditions and that this rate is increased about two-fold
by ANP exposure. siRNA knock down of clathrin and
dominant negative inhibition of dynamin failed to inhibit
ANP-dependent NPR-A degradation, whereas dominant
negative dynamin expression reduced the rate of NPR-A
internalization about 40%.
Conclusion
These data indicate that NPR-A is basally internalized by a
dynamin-dependent pathway and that prolonged ANP
exposure stimulates both NPR-A internalization and deg-
radation.
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